| Literature DB >> 27566558 |
Xiao Ma1, Wei-Guo Tang1, Yang Yang1, Qing-Li Zhang1, Jia-Li Zheng2, Yong-Bing Xiang1.
Abstract
Some observational studies have examined the association between dietary whole grain intake and all-cause mortality, but the results were inconclusive. We therefore conducted a meta-analysis to summarize the evidence from cohort studies regarding the association between whole grain intake and all-cause mortality. Pertinent studies were identified by searching PubMed, Embase and Web of Knowledge, up to February 28, 2016. Study-specific estimates were combined using random-effects models. Eleven prospective cohort studies involving 101,282 deaths and 843,749 participants were included in this meta-analysis. The pooled relative risk of all-cause mortality for the highest category of whole grain intake versus lowest category was 0.82 (95% confidence interval: 0.78, 0.87). There was a 7% reduction in risk associated with each 1 serving/day increase in whole grain intake (relative risk = 0.93; 95% confidence interval: 0.89, 0.97). No publication bias was found. This analysis indicates that higher intake of whole grain is associated with a reduced risk of all-cause mortality. The findings support current recommendations for increasing whole grain consumption to promote health and overall longevity.Entities:
Keywords: diet; meta-analysis; mortality; prospective cohort studies; whole grain intake
Mesh:
Year: 2016 PMID: 27566558 PMCID: PMC5308706 DOI: 10.18632/oncotarget.11491
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Figure 1Process used to select prospective cohort studies for a meta-analysis of the association between whole grain intake and all-cause mortality, 1964–2016
Figure 2Forest plot (random-effects model) of the association between whole grain intake (highest category vs. lowest) and all-cause mortality
Black points indicate study-specific RRs (the size of the square reflects the study-specific statistical weight); horizontal lines indicate 95% CIs; the diamond indicates the summary estimate with its 95% CI.
Figure 3Forest plot (random-effects model) of the association between whole grain intake (each 1 serving/d increase) and all-cause mortality
Black points indicate study-specific RRs (the size of the square reflects the study-specific statistical weight); horizontal lines indicate 95% CIs; the diamond indicates the summary estimate with its 95% CI.
Pooled relative risk of all-cause mortality for persons in the highest category of whole grain intake versus those in the lowest category in a meta-analysis, by study characteristic, 2001–2016
| Studies | Summary RR | 95% CI | ||||
|---|---|---|---|---|---|---|
| All studies | 10 | 0.82 | (0.78, 0.87) | 76.6 | < 0.001 | |
| Gender | 0.725 | |||||
| Male | 2 | 0.85 | (0.67, 1.07) | 94.3 | < 0.001 | |
| Female | 4 | 0.80 | (0.72, 0.88) | 77.3 | 0.004 | |
| Male + Female | 5 | 0.83 | (0.80, 0.85) | 0 | 0.673 | |
| Study location | 0.143 | |||||
| America | 7 | 0.85 | (0.80, 0.90) | 74.4 | < 0.001 | |
| Europe | 3 | 0.75 | (0.71, 0.80) | 0 | 0.558 | |
| Follow-up time | 0.686 | |||||
| > 15 | 5 | 0.83 | (0.75, 0.91) | 88.1 | < 0.001 | |
| ≤ 15 | 5 | 0.82 | (0.80, 0.85) | 0 | 0.673 | |
| Cohort size | 0.388 | |||||
| > 35,000 | 5 | 0.84 | (0.78, 0.90) | 88.1 | < 0.001 | |
| ≤ 35,000 | 5 | 0.78 | (0.73, 0.84) | 0 | 0.886 | |
| Adjustment for: | ||||||
| BMI | 0.707 | |||||
| Yes | 8 | 0.83 | (0.76, 0.90) | 80.0 | < 0.001 | |
| No | 2 | 0.82 | (0.76, 0.88) | 28.8 | 0.236 | |
| Physical activity level | 0.241 | |||||
| Yes | 9 | 0.84 | (0.79, 0.89) | 69.5 | 0.001 | |
| No | 1 | 0.75 | (0.70, 0.80) | NA | NA | |
| Alcohol consumption | 0.411 | |||||
| Yes | 9 | 0.83 | (0.78, 0.88) | 77.9 | < 0.001 | |
| No | 1 | 0.75 | (0.65, 0.88) | NA | NA | |
| Diabetes | 0.253 | |||||
| Yes | 8 | 0.84 | (0.79, 0.89) | 73.3 | < 0.001 | |
| No | 2 | 0.75 | (0.70, 0.80) | 0 | 0.701 | |
| Blood pressure | 0.090 | |||||
| Yes | 5 | 0.87 | (0.80, 0.94) | 64.6 | 0.023 | |
| No | 5 | 0.79 | (0.75, 0.84) | 54.1 | 0.069 | |
| Serum cholesterol level | 0.063 | |||||
| Yes | 3 | 0.88 | (0.80, 0.96) | 79.2 | 0.008 | |
| No | 7 | 0.79 | (0.76, 0.83) | 35.9 | 0.154 |
BMI, body mass index; CI, confidence interval; NA, not available; RR, relative risk.
P value for heterogeneity within each subgroup.
P value for heterogeneity between subgroups in meta-regression analysis.
The median follow-up time for studies included in the meta-analysis was 15 years.
The median cohort size for studies included in the meta-analysis was 35,000 participants.
Studies excluding prevalent diabetes at baseline were included in the “yes” group.